ArticleUrology2011

Interleukin-6: a potential biomarker of resistance to multitargeted receptor tyrosine kinase inhibitors in castration-resistant prostate cancer.

Alexander Kutikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.